{"id":"NCT02335346","sponsor":"Eli Lilly and Company","briefTitle":"An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)","officialTitle":"An Open Label Extension Study of Phase 3 Trial of Duloxetine in Patients With Osteoarthritis and Knee Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01","primaryCompletion":"2016-03","completion":"2016-03","firstPosted":"2015-01-09","resultsPosted":"2017-11-07","lastUpdate":"2019-09-18"},"enrollment":93,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis of the Knee"],"interventions":[{"type":"DRUG","name":"Duloxetine","otherNames":["LY248686","Cymbalta"]}],"arms":[{"label":"Duloxetine","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the safety and efficacy of duloxetine in participants with osteoarthritis and knee pain. The study will last for 1 year.","primaryOutcome":{"measure":"Percentage of Participants With Drug Related Adverse Events (AEs) or Any Serious Adverse Events (SAEs)","timeFrame":"Baseline through Week 53","effectByArm":[{"arm":"Duloxetine","deltaMin":51.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":24},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":93},"commonTop":["Constipation","Nasopharyngitis","Somnolence","Thirst","Contusion"]}}